Duomodiag Sàrl
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Duomodiag Sàrl - overview
Location
Luxembourg, -, Luxembourg
Primary Industry
Business Support Services
About
Duomodiag Sàrl is a Luxembourg-based holding company established as a special purpose acquisition vehicle (SPV) to facilitate private equity investments in the healthcare sector. The entity is backed by ARCHIMED, a global healthcare-focused private equity firm, through its MED II fund. The company was specifically formed to execute the acquisition of DIESSE Diagnostica Senese S. p.
A. in 2019, acting as the legal buyer in the transaction. As a transaction-specific holding entity, Duomodiag Sàrl does not operate as an independent commercial business. Instead, it functions as an investment and ownership structure, enabling ARCHIMED to hold, manage, and support its portfolio investment.
Current Investors
Archimed
Primary Industry
Business Support Services
Sub Industries
Business Support Services
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Duomodiag Sàrl - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Carve Out, Secondary Buyout | Completed | DIESSE Diagnostica Senese S.p.A. | - | ||||||||
| Buyout | Completed | Duomodiag Sàrl | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.